Table 1.
Contribution | Phenotype | Normalization | h2 | Covariates | CpG probes | Model(s) | Software |
---|---|---|---|---|---|---|---|
Almeida et al. [22] | HDL | Inverse | Pre and post fenofibrate HDL and CpG sites | 20 PCs | Epigenome-wide | VC-LME | SOLAR |
Canty and Paterson [20] | TG, QC | Probe type strata | – | 4 PCs Difference in TGs |
Epigenome-wide | Standard linear model (t-test) | |
Fernandez-Rhodes et al. [25] | Metabolic syndrome | Type II probes | Metabolic syndrome, 4 CpG sites | age, sex, SNPs, center, smoking, PCs | 4 CpG sites | VC-LME | SOLAR |
LeBlanc et al. [21] | QC only | BMIQ | Used breeding values from a heritability model | Age, sex, SNPs | Epigenome-wide | Bayesian LME | R-INLA |
Lim et al. [23] | TG | BMIQ | Age, sex, study, center, smoking, 10 PCs | 14,850 CpG sites showing | LME | WGCNA, missmethyl | |
Nustad et al. [24] | TG, HDL | BMIQ | P-to-e and post fenofibrate, TG HDL and CpG sites | Age, sex | Epigenome-wide | Bayesian LME | R-package INLA |
Yu et al. [26] | TG | – | Age, sex, study center, smoking status, HDL | 349,755 CpG sites | GEE | R 3.2 |
All contributions in this group used the GAW20 real data set
BMIQ beta-mixture quantile normalization method for correcting probe design bias, GEE generalized estimating equation, HDL high-density lipoprotein, h2 denotes heritability and indicates if the paper has estimated this quantity, INLA integrated nested Laplace approximation, PC DNA methylation-derived principal component and indicates this study employed PCs as covariates in their analysis, QC quality control, SOLAR sequential oligogenic linkage analysis routines, SNP single-nucleotide polymorphism, TG triglyceride, VC-LME variance component linear mixed effect, WGCNA weighted gene coexpression network analysis